[Role of G-CSF for breast cancer chemotherapy]

Nihon Rinsho. 2007 Jun 28:65 Suppl 6:572-4.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Drug Administration Schedule
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Humans
  • Neutropenia / chemically induced*
  • Neutropenia / prevention & control*
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects

Substances

  • Granulocyte Colony-Stimulating Factor
  • Doxorubicin
  • Cyclophosphamide
  • Paclitaxel